Ofer Lavie

Summary

Country: Israel

Publications

  1. ncbi Computerized nuclear morphometry for the prediction of inguinal lymph nodes metastases in squamous cell carcinoma of the vulva
    O Lavie
    Gynecologic Oncology Unit, Carmel Medical Center, Haifa, Israel
    Int J Gynecol Cancer 16:556-61. 2006
  2. ncbi BRCA germline mutations in Jewish women with uterine serous papillary carcinoma
    Ofer Lavie
    Division of Gynecologic Oncology, Carmel Medical Center, Haifa 34362, Israel
    Gynecol Oncol 92:521-4. 2004
  3. ncbi Conservative management for villoglandular papillary adenocarcinoma of the cervix diagnosed during pregnancy followed by a successful term delivery: a case report and a review of the literature
    O Lavie
    Division of Gynecological Oncology, Carmel Medical Center, 7 Michal Street, Haifa 34362, Israel
    Eur J Surg Oncol 34:606-8. 2008
  4. ncbi The outcome of patients with stage I endometrial cancer involving the lower uterine segment
    O Lavie
    Department of Obstetrics and Gynecology, Carmel Medical Center, Haifa, Israel
    Int J Gynecol Cancer 18:1079-83. 2008
  5. doi The risk of developing uterine sarcoma after tamoxifen use
    O Lavie
    Department of Obstetrics and Gynecology, Division of Gynecology and Oncology, Carmel Medical Center, Haifa, Israel
    Int J Gynecol Cancer 18:352-6. 2008
  6. doi BRCA germline mutations in women with uterine serous carcinoma--still a debate
    Ofer Lavie
    Department of Obstetrics and Gynecology, Carmel Medical Center, Haifa, Israel
    Int J Gynecol Cancer 20:1531-4. 2010
  7. ncbi BRCA2 germline mutation in a woman with uterine serous papillary carcinoma--case report
    Ofer Lavie
    Division of Gynecological Oncology, Carmel Medical Center, 7 Michal Street, Haifa 34362, Israel
    Gynecol Oncol 99:486-8. 2005
  8. doi The effect of statins on risk and survival of gynecological malignancies
    Ofer Lavie
    Gyneco Oncology Unit, Department of Obstetrics and Gynecology, Carmel Medical Center and Bruce Rappaport Faculty of Medicine, Technion Israel Institute of Technology and Clalit Health Services National Cancer Control Center, Haifa, Israel
    Gynecol Oncol 130:615-9. 2013
  9. ncbi Conservative treatment of stage IA2 squamous cell carcinoma of the cervix during pregnancy
    Alon Ben-Arie
    Department of Obstetrics and Gynecology, Kaplan Medical Center, Hebrew University and Hadassah Medical School, Rehovot, Israel
    Obstet Gynecol 104:1129-31. 2004
  10. doi Pretreatment CA 15-3 levels do not predict disease-free survival in patients with advanced epithelial ovarian cancer
    Ofer Gemer
    Department of Obstetrics and Gynecology, Barzilai Medical Center, Ashkelon, Israel
    Tumori 99:257-60. 2013

Collaborators

Detail Information

Publications51

  1. ncbi Computerized nuclear morphometry for the prediction of inguinal lymph nodes metastases in squamous cell carcinoma of the vulva
    O Lavie
    Gynecologic Oncology Unit, Carmel Medical Center, Haifa, Israel
    Int J Gynecol Cancer 16:556-61. 2006
    ..The results of our study justify the need for a prospective study of a larger number of patients to evaluate the reproducibility and the clinical use of the data...
  2. ncbi BRCA germline mutations in Jewish women with uterine serous papillary carcinoma
    Ofer Lavie
    Division of Gynecologic Oncology, Carmel Medical Center, Haifa 34362, Israel
    Gynecol Oncol 92:521-4. 2004
    ..The purpose of this study was to determine the incidence of these mutations in an enlarged series of USPC...
  3. ncbi Conservative management for villoglandular papillary adenocarcinoma of the cervix diagnosed during pregnancy followed by a successful term delivery: a case report and a review of the literature
    O Lavie
    Division of Gynecological Oncology, Carmel Medical Center, 7 Michal Street, Haifa 34362, Israel
    Eur J Surg Oncol 34:606-8. 2008
  4. ncbi The outcome of patients with stage I endometrial cancer involving the lower uterine segment
    O Lavie
    Department of Obstetrics and Gynecology, Carmel Medical Center, Haifa, Israel
    Int J Gynecol Cancer 18:1079-83. 2008
    ..A larger group of patients is necessary to conclude whether higher recurrence rate and poorer overall survival are associated with the presence of LUSI...
  5. doi The risk of developing uterine sarcoma after tamoxifen use
    O Lavie
    Department of Obstetrics and Gynecology, Division of Gynecology and Oncology, Carmel Medical Center, Haifa, Israel
    Int J Gynecol Cancer 18:352-6. 2008
    ..08). We conclude that in this national breast cancer cohort, tamoxifen use was associated with elevated risks of uterine cancer incidence and mortality. Uterine sarcomas appear to be overrepresented among women who use tamoxifen...
  6. doi BRCA germline mutations in women with uterine serous carcinoma--still a debate
    Ofer Lavie
    Department of Obstetrics and Gynecology, Carmel Medical Center, Haifa, Israel
    Int J Gynecol Cancer 20:1531-4. 2010
    ....
  7. ncbi BRCA2 germline mutation in a woman with uterine serous papillary carcinoma--case report
    Ofer Lavie
    Division of Gynecological Oncology, Carmel Medical Center, 7 Michal Street, Haifa 34362, Israel
    Gynecol Oncol 99:486-8. 2005
    ..Recently, a high incidence of BRCA1 cancer predisposing mutation was described among patients with Uterine Serous Papillary Carcinoma (USPC). A BRCA2 germline mutation in a USPC patient has never been reported...
  8. doi The effect of statins on risk and survival of gynecological malignancies
    Ofer Lavie
    Gyneco Oncology Unit, Department of Obstetrics and Gynecology, Carmel Medical Center and Bruce Rappaport Faculty of Medicine, Technion Israel Institute of Technology and Clalit Health Services National Cancer Control Center, Haifa, Israel
    Gynecol Oncol 130:615-9. 2013
    ..The use of statins has been associated with reduced risk of malignancies in a variety of organ sites. This study was aimed at studying the effects of statins on gynecological cancers...
  9. ncbi Conservative treatment of stage IA2 squamous cell carcinoma of the cervix during pregnancy
    Alon Ben-Arie
    Department of Obstetrics and Gynecology, Kaplan Medical Center, Hebrew University and Hadassah Medical School, Rehovot, Israel
    Obstet Gynecol 104:1129-31. 2004
    ..We describe a case of early invasive cervical cancer in pregnancy that was treated with a conservative surgical approach...
  10. doi Pretreatment CA 15-3 levels do not predict disease-free survival in patients with advanced epithelial ovarian cancer
    Ofer Gemer
    Department of Obstetrics and Gynecology, Barzilai Medical Center, Ashkelon, Israel
    Tumori 99:257-60. 2013
    ..To evaluate the role of pretreatment CA 15-3 levels as a predictor of disease-free survival in patients with advanced epithelial ovarian cancer...
  11. doi Gynecologic malignancies in Ashkenazi families with the MSH2 A636P founder mutation
    Ofer Lavie
    Division of Gynecology and Oncology, Carmel Medical Center, B Rappaport Faculty of Medicine, Technion, Haifa, Israel
    Am J Obstet Gynecol 199:148.e1-3. 2008
    ..Although the incidence of colorectal cancer in carriers is relatively well established, the frequency of other tumors is less clear...
  12. doi Ovarian carcinosarcomas associated with prolonged use of tamoxifen: case reports
    Ofer Lavie
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Carmel Medical Center, Haifa, Israel
    Int J Gynecol Cancer 19:1521-3. 2009
    ..Recent studies have indicated that the risk associated with tamoxifen may be substantially higher for uterine malignant mixed müllerian tumors and uterine sarcomas...
  13. ncbi Intratumoral CD8+ T lymphocytes as a prognostic factor of survival in endometrial carcinoma
    Svetlana Kondratiev
    Department of Pathology and Division of Gynecologic Oncology, Carmel Medical Center and the Technion Rappoport Faculty of Medicine, Haifa, Israel
    Clin Cancer Res 10:4450-6. 2004
    ..The objective of this study was to evaluate the distribution pattern and prognostic value of CD8(+) T cells in endometrial carcinoma...
  14. ncbi Multidrug resistance-related phenotype and apoptosis-related protein expression in ovarian serous carcinomas
    Evgeny Yakirevich
    Department of Pathology, Carmel Medical Center and Rappaport Faculty of Medicine, Technion University, Haifa, Israel
    Gynecol Oncol 100:152-9. 2006
    ..In addition, we correlated expression of these proteins with the apoptosis-related proteins p53, bcl-2, and bax...
  15. doi Symptomatic pelvic hematoma following transvaginal reconstructive pelvic surgery: incidence, clinical presentation, risk factors, and outcome
    Yakir Segev
    Division of Urogynecology and Reconstructive Pelvic Surgery, Department of Obstetrics and Gynecology, Carmel Medical Center, Technion University, Rappaport Faculty of Medicine, 7 Michal St, Haifa 34362, Israel
    Eur J Obstet Gynecol Reprod Biol 153:211-4. 2010
    ..To assess the incidence, clinical presentation, risk factors and outcome of symptomatic pelvic hematomas following transvaginal pelvic reconstructive surgery...
  16. ncbi Outcome after combined modality treatment for uterine papillary serous carcinoma: a study by the Rare Cancer Network (RCN)
    Hadassah Goldberg
    Division of Oncology, Rambam Health Care Campus and Rappaport Faculty of Medicine, Technion, Haifa, Israel
    Gynecol Oncol 108:298-305. 2008
    ..Uterine papillary serous carcinoma (UPSC) is a rare subtype of endometrial carcinoma, characterized by a poor outcome. We sought to better analyze the effect of surgery and adjuvant therapies on this disease...
  17. ncbi Statins, aspirin and risk of venous thromboembolic events in breast cancer patients
    Ayelet Shai
    Department of Oncology, Clalit Health Services, Lin and Carmel Medical Centers, 35 Rotchild St, Haifa, Israel
    J Thromb Thrombolysis 38:32-8. 2014
    ..In our cohort, statin and aspirin use did not decrease the risk for a VTE. Our results might be explained by use of low potency statins (simvastatin and pravastatin) and by alternate mechanisms for VTE formation in patients with cancer. ..
  18. ncbi Cervical intraepithelial neoplasia 2, 3 in pregnancy: time to consider loop cone excision in the first trimester of pregnancy?
    Efraim Siegler
    1Colposcopy and Cervix Clinic, Department of Gynecology and Obstetrics, Carmel Medical Center and 2Department of Gynecology and Obstetrics Rambam Medical Center, Rappaport Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel
    J Low Genit Tract Dis 18:162-8. 2014
    ....
  19. doi Are women with pelvic organ prolapse at a higher risk of developing hernias?
    Yakir Segev
    Division of Urogynecology and Reconstructive Pelvic Surgery, Department of Obstetrics and Gynecology, Carmel Medical Center, Rappaport Faculty of Medicine, Technion University, 7 Michal St, Haifa, 34362, Israel
    Int Urogynecol J Pelvic Floor Dysfunct 20:1451-3. 2009
    ..Pelvic organ prolapse and hernia are common disorders which share several pathopysiological and epidemiological features. We therefore aimed to assess whether women with advanced pelvic organ prolapse have a higher prevalence of hernia...
  20. ncbi Integrating complementary medicine in supportive cancer care models across four continents
    Eran Ben-Arye
    Integrative Oncology Program, The Oncology Service, Lin Medical Center, Clalit Health Services, 35 Rothschild St, Haifa, Western Galilee, Israel
    Med Oncol 30:511. 2013
    ..Integration of CM consultation within oncological supportive care needs to take in account six key elements that ensure high-quality evidence-based concomitant integrative practice...
  21. doi The role of CPK isoenzymes in predicting extrauterine early pregnancy
    Jenya Kruchkovich
    Department of Obstetrics and Gynecology, Barzilai Medical Center, Ben Gurion University of the Negev, Ashkelon, Israel
    Arch Gynecol Obstet 286:135-7. 2012
    ..To evaluate the ability of Creatine phosphokinase (CPK) levels and CPK-MB proportion to differentiate between extra and intrauterine of very early gestations with unknown location...
  22. ncbi Reduction of postmolar gestational trophoblastic neoplasia by early diagnosis and treatment
    Alon Ben-Arie
    Department of Obstetrics and Gynecology, Kaplan Medical Center, Rehovot, Israel
    J Reprod Med 54:151-4. 2009
    ..To compare contemporary and historical clinical presentation of complete moles (CMs) and the rates of gestational trophoblastic neoplasia (GTN)...
  23. doi Diameter-by-age reference curves for the uterine cervix by computerized tomography
    Ofer Gemer
    Department of Obstetrics and Gynecology, Barzilai Medical Center, Ashkelon, Israel
    J Comput Assist Tomogr 33:405-7. 2009
    ..To create diameter-by-age reference curves for the uterine cervix using computerized tomographic studies...
  24. pmc Use of hormone replacement therapy and the risk of colorectal cancer
    Gad Rennert
    Department of Community Medicine and Epidemiology, Carmel Medical Center, 7 Michal St, Haifa 34362, Israel
    J Clin Oncol 27:4542-7. 2009
    ..Such treatments have formerly been shown to be associated with lower colorectal cancer risk in an as yet unknown mechanism...
  25. ncbi Pelvic splenosis mimicking an ovarian mass: a non-invasive approach
    Yakir Segev
    Department of Obstetrics and Gynecology, Carmel Medical Center, Haifa, Israel
    Isr Med Assoc J 9:819-20. 2007
  26. ncbi [Post hysterectomy vaginal vault prolapse: diagnosis prevention and treatment]
    Yakir Segev
    Division of Urogynecology and Reconstructive Pelvic Surgery, Department of Obstetrics and Gynecology, Carmel Medical Center, Technion Faculty of Medicine, Haifa, Israel
    Harefuah 147:406-12, 478. 2008
    ..Our knowledge of the pathophysiology of post hysterectomy vaginal vault prolapse is quickly being refined, leading to more efficient surgical therapies for prevention and treatment of this disorder...
  27. doi Displacement of ureteral orifices following anterior colporrhaphy
    Lena Dain
    Division of Urogynecology and Reconstructive Pelvic Surgery, Haifa, Israel
    Int Urogynecol J 21:43-5. 2010
    ..It is currently unknown whether ureteral orifices maintain their anatomic location after reconstructive pelvic surgeries. We therefore aimed to assess ureteral orifices' location after anterior colporrhaphy...
  28. doi Uterine inversion associated with uterine sarcoma
    Ofer Gemer
    Department of Obstetrics and Gynecology, Barzilai Medical Center, Ashkelon, Israel
    Int J Gynaecol Obstet 101:195-6. 2008
  29. doi Assisted reproductive technologies: medical safety issues in the older woman
    Yakir Segev
    Department of Obstetrics and Gynecology, The Lady Davis Carmel Medical Center, Rappaport Faculty of Medicine, Technion, 7 Michal Street, Haifa, Israel
    J Womens Health (Larchmt) 20:853-61. 2011
    ..This assessment should include a thorough medical questionnaire and medical examination. Further evaluation and treatment should follow to ensure the safety of ART procedures and of ensuing pregnancies...
  30. doi The reproducibility of histological parameters employed in the novel binary grading systems of endometrial cancer
    O Gemer
    Department of Obstetrics and Gynecology, Barzilai Medical Center, Ashkelon, Israel
    Eur J Surg Oncol 35:247-51. 2009
    ..To compare the interobserver reproducibility and prognostic value of the FIGO grading system with the histological parameters employed in the various recently proposed binary grading systems of endometrial cancer...
  31. ncbi Lymphvascular space involvement compromises the survival of patients with stage I endometrial cancer: results of a multicenter study
    O Gemer
    Department of Obstetrics and Gynecology, Barzilai Medical Center, Ashkelon, Israel
    Eur J Surg Oncol 33:644-7. 2007
    ..To quantify the relative risk associated with lymphvascular space involvement (LVSI) on outcome measures in patients with apparent stage I endometrial cancer...
  32. doi Integrating a complementary medicine consultation for women undergoing chemotherapy
    Eran Ben-Arye
    Integrative Oncology Program, Oncology Service, Lin Medical Center, Clalit Health Services, Haifa, Israel Complementary and Traditional Medicine Unit, Department of Family Medicine, Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel Electronic address
    Int J Gynaecol Obstet 124:51-4. 2014
    ..To explore oncology healthcare providers' (HCPs') patterns of referral of women undergoing chemotherapy to a complementary medicine (CM) consultation integrated within a conventional oncology service...
  33. doi To operate or to radiate: the added value of the maximal standardized uptake value in PET-FDG in cervical cancer patients
    Itamar Netzer
    Gynecological Oncology Unit, Department of Obstetrics and Gynecology, Rambam Health Care Campus, 8 Haaliya St, Haifa, Israel
    Med Oncol 30:558. 2013
    ..8 %. SUVmax can be used for differentiating early-stage cervical cancer patients who will need postoperative adjuvant treatment and therefore can serve as an additional modality to reduce the need for bimodal therapy in these patients...
  34. ncbi [Human papillomavirus types in women with cervical cancer in Haifa District]
    Efraim Siegler
    Cervix CLinic, Department of Obstetrics and Gynecology, Carmel Medical Center Serology Laboratory, Carmel Medical Center
    Harefuah 150:837-41, 876. 2011
    ..HPV 16 and 18 are detected in 70% of the cases. Two vaccines against HPV 16 and 18 were approved for use in Israel in recent years...
  35. ncbi [Medical evaluation prior to fertility treatment--time for reconsideration?]
    Segev Yakir
    Department of Obstetrics and Gynecology, The Lady Davis Carmel Medical Center, Rappaport Faculty of Medicine, Technion, Haifa, Israel
    Harefuah 150:844-8, 875. 2011
    ..At the end of the evaluation, and before ART treatment, the women should be consulted, based on the results of tests, on the possible risks that might accompany the ART procedure, pregnancy and delivery...
  36. doi Effect of closure versus nonclosure of peritoneum at cesarean section on adhesions: a prospective randomized study
    Victoria Kapustian
    Department of Obstetrics and Gynecology, Barzilai Medical Center Faculty of Health Sciences, Ben Gurion University of the Negev, Ashkelon, Israel
    Am J Obstet Gynecol 206:56.e1-4. 2012
    ..We sought to determine the effect of nonclosure of the visceral and parietal peritoneum during cesarean section on the formation of adhesions...
  37. ncbi Treatment of recurrent inguinal lymphocele by lymphatic leakage mapping and subsequent ligation of lymphatic vessel endings: a case report
    Ofer Lavie
    Division of Gynecologic Surgery and Oncology, Carmel Medical Center, Haifa, Israel
    Gynecol Oncol 84:155-6. 2002
    ..We hereby report our preliminary experience with mapping of the lymphatic leakage followed by ligation of these mapped vessels for resolution of a recurrent inguinal lymphocele...
  38. doi Complementary medicine in the primary care setting: Results of a survey of gender and cultural patterns in Israel
    Eran Ben-Arye
    Complementary and Traditional Medicine Unit, Department of Family Medicine, Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel
    Gend Med 6:384-97. 2009
    ..The purpose of this study was to examine the use of complementary and alternative medicine (CAM) in a primary care practice in Israel to determine prevalence and patterns of use...
  39. pmc Laparoscopic removal of an intrauterine device following colon perforation
    Arie Bitterman
    Department of Surgery A, Carmel Medical Center, Haifa, Israel
    JSLS 14:456-8. 2010
    ..Intrauterine device (IUD) migration and colon perforation is a rare but serious complication occurring sometimes years after insertion. Laparoscopic removal of a colon-perforating device is a seldom-used approach...
  40. ncbi Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens in serous ovarian neoplasms
    Evgeny Yakirevich
    Department of Pathology, Carmel Medical Center and Rappaport Faculty of Medicine, Technion University, Haifa, Israel
    Clin Cancer Res 9:6453-60. 2003
    ..The objective of this study was to evaluate the extent and prognostic significance of CT antigen expression in ovarian serous neoplasms...
  41. ncbi Pregnancy outcome after laparoscopy or laparotomy in pregnancy
    Gabriel Oelsner
    Department of Obstetrics and Gynecology, Sheba Medical Center, Tel Hashomer, Israel
    J Am Assoc Gynecol Laparosc 10:200-4. 2003
    ..To assess obstetric performance and fetal outcomes after laparoscopy or laparotomy performed during pregnancy...
  42. ncbi The management of an early-missed abortion after radical trachelectomy--a case report and a review of the literature
    O Lavie
    Department of Obstetrics and Gynecology, Gynecologic Oncology Division, Carmel Medical Center, Affiliated with Technion Institute of Technology, Faculty of Medicine, Haifa, Israel
    Int J Gynecol Cancer 16:1688-90. 2006
    ..Radical trachelectomy (RT) has been reported for almost 20 years. This case report describes and addresses the issue of the clinical management of early-missed abortion in a patient after RT with a cerclage...
  43. ncbi Placental shelf - a common, typically transient and benign finding on early second-trimester sonography
    O Shen
    Department of Obstetrics and Gynecology, Shaare Zedek Medical Center, Jerusalem, affiliated to Faculty of Health Sciences, Ben Gurion University of Negev, Be er Sheva, Israel
    Ultrasound Obstet Gynecol 29:192-4. 2007
    ..The objective of this study was to determine the prevalence, persistence and significance of placental shelves detected in the early second trimester...
  44. ncbi Endometrial ablation for the postmenopausal woman
    A Lissak
    Department of Obstetrics and Gynecology, Carmel Medical Center and Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel
    J Am Assoc Gynecol Laparosc 8:601-2. 2001
    ..In the subgroup of postmenopausal women taking hormone replacement therapy (HRT), the risk of abnormal bleeding is by far higher, is the main reason for discontinuing HRT, and deserves additional attention...
  45. ncbi Decreased level of the cell cycle regulator p27 and increased level of its ubiquitin ligase Skp2 in endometrial carcinoma but not in normal secretory or in hyperstimulated endometrium
    S Lahav-Baratz
    Department of Obstetrics, Carmel Medical Center, Haifa, Israel
    Mol Hum Reprod 10:567-72. 2004
    ..In striking contrast, p27 is significantly lower while Skp2 and Ki67 are significantly higher in the endometrial carcinoma and in endometrium from the proliferative phase compared with their normal secretory counterpart tissue...
  46. ncbi Does hysteroscopy affect prognosis in apparent early-stage endometrial cancer?
    A Ben-Arie
    Department of Obstetrics and Gynecology, Kaplan Medical Center, Rehovot, Israel
    Int J Gynecol Cancer 18:813-9. 2008
    ....
  47. ncbi Prophylactic effect of the open vaginal vault method in reducing febrile morbidity in abdominal hysterectomy
    M Neuman
    Department of Obstetrics and Gynecology, Shaare Zedek Medical Center, Jerusalem, Israel
    Surg Gynecol Obstet 176:591-3. 1993
    ..The vaginal vault was left open in 72 patients and closed in 65 patients in control groups. No significant difference in postoperative febrile morbidity was noticed in the two groups...
  48. ncbi Lower uterine segment involvement is associated with adverse outcome in patients with stage I endometroid endometrial cancer: results of a multicenter study
    O Gemer
    Department of Obstetrics and Gynecology, Barzilai Medical Center, Ashkelon, Israel
    Eur J Surg Oncol 35:865-9. 2009
    ..To quantify the relative risk associated with lower uterine segment involvement (LUSI) on outcome measures in patients with apparent stage I endometroid endometrial cancer...
  49. doi RE: "Office hysteroscopy and the risk of microscopic extrauterine spread in endometrial cancer"
    Ofer Lavie
    Gynecol Oncol 110:266-7; author reply 267-8. 2008
  50. ncbi The RASSF1A tumor suppressor gene is commonly inactivated in adenocarcinoma of the uterine cervix
    Yoram Cohen
    Department of Otolaryngology Head and Neck Surgery, The Johns Hopkins University, Baltimore, Maryland 21205, USA
    Clin Cancer Res 9:2981-4. 2003
    ..The 20 cases of cervical AC were also analyzed for the presence of oncogenic HPV 16 DNA using a PCR-based method...
  51. ncbi Outcome of fertility-sparing treatment with progestins in young patients with endometrial cancer
    Ofer Lavie
    Obstet Gynecol 103:997-8; author reply 998. 2004